Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein.

Signal Transduct Target Ther · 2024 · PMC11163014 · PMID 38853183

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

highly significantP < 0.05actually significant

P ‐values were calculated, and statistical significance was expressed as highly significant with * P < 0.05, ** P < 0.01, *** P < 0.001.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.